Drug Price Lookup
Live pharmacy acquisition cost (CMS NADAC) for any US drug — by strength, with effective dates.
Aripiprazole (brands: ABILIFY, ABILIFY MAINTENA, Abilify Asimtufii)
| Strength | Acquisition cost | Effective |
|---|---|---|
| 1 MG/ML Solution | $0.3955/unit | 10/21/2026 |
| 10 MG Tablet | $0.0997/unit | 05/20/2026 |
| 15 MG Tablet | $0.1338/unit | 10/21/2026 |
| 2 MG Tablet | $0.1034/unit | 08/19/2026 |
| 20 MG Tablet | $0.1673/unit | 08/19/2026 |
| 30 MG Tablet | $0.1646/unit | 08/19/2026 |
| 300 MG | $2138.0285/unit | 10/21/2026 |
| 400 MG | $2852.0013/unit | 10/21/2026 |
| 5 MG Tablet | $0.1041/unit | 08/19/2026 |
| 720 MG/2.4 | $1786.4257/unit | 10/21/2026 |
Full profile — coverage, spending, alternatives: rxfinder.ai/drug/aripiprazole
NADAC is what pharmacies actually pay to acquire the drug — the honest baseline for judging what a plan is charged.
Data: CMS NADAC (National Average Drug Acquisition Cost) — NADAC effective 10/21/2026 · source
Machine access — this tool is available as structured data for AI assistants and agents:
GET https://rxfinder.ai/tools/drug-price/data.json?drug=aripiprazole